Cresco Labs (CRLBF) Treasury Shares (2019 - 2023)
Cresco Labs (CRLBF) posted Treasury Shares of $121.9 billion for Q4 2019.
Cresco Labs (CRLBF) Treasury Shares (2019 - 2023) Analysis & Trends
Cresco Labs' Treasury Shares history runs 1 years deep, the most recent figure standing at $121.9 billion for Q4 2019.
- Quarterly Treasury Shares changed N/A year-over-year to $121.9 billion in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $121.9 billion (changed N/A YoY) and the FY2019 annual result came in at $121.3 billion, changed N/A from the prior year.
- Treasury Shares was $121.9 billion for Q4 2019 at Cresco Labs.
- Across five years, Treasury Shares topped out at $121.9 billion in Q4 2019 and bottomed at $121.9 billion in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 96.70 Mn |
| Dec 31, 2023 | 96.70 Mn |
| Dec 31, 2019 | 121.95 Bn |
| Dec 31, 2019 | 121.95 Bn |